Navigation Links
Paramount Completes Acquisition of Chem Rx
Date:10/26/2007

re based upon the current beliefs and expectations of Paramount's or Chem Rx's management and are subject to risks and uncertainties that could cause actual results to differ from the forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward- looking statements: compliance with government regulations; changes in legislation or regulatory environments; requirements or changes adversely affecting the health care industry, including changes in Medicare reimbursement policies; fluctuations in customer demand; management of rapid growth; intensity of competition; timing, approval and market acceptance of new product introductions; general economic conditions; geopolitical events and regulatory changes, as well as other relevant risks detailed in Paramount's filings with the SEC, including its Annual Report on Form 10-KSB for the year ended December 31, 2006. The information set forth herein should be read in light of such risks. Paramount does not assume any obligation to update the information contained in this press release.

Contacts:

J. Jay Lobell Stephanie Carrington /

Chief Executive Officer & Elizabeth Scott

Secretary The Ruth Group

Paramount Acquisition Corp. 646-536- 7017 / 7014

(212) 554-4522 scarrington@theruthgroup.com

jlobell@paramountbio.com escott@theruthgroup.com


'/>"/>
SOURCE Paramount Acquisition Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. iGATE Completes Phase I Testing Of Meningitis Vaccine
2. Delhi Hospital Completes 100 Liver Transplants
3. Roche Completes Acquisition of BioVeris
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
6. NHS financial crisis may lead to roll back of flexi-work scheme and private acquisition
7. Smoking Increases Risk of HIV Acquisition
8. Circassia Announces Acquisition of Organ Transplant Anti-Rejection Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...UCCESS, N.Y., July 25 /PRNewswire-USNewswire/ -- A...ief Quality Officer and Vice President,of Strategi...alth Fund, a,national foundation committed to impr...ected the foundation,s Program on Health Care Qual...ww.newscom.com/cgi-bin/prnh/20080725/DC28791LOGO ...
(Date:7/25/2008)...ty of Phoenix employees at 62 campuses, 43 affilia...lp feed nation,s hungry, PHOENIX, July 25 /PRNews...n,s hungry as employees at University of Phoenix, ...artments and four subsidiaries collected,enough no...provide more,than 68,000 meals. The staggering tot...
(Date:7/25/2008)...mmune response after antiretroviral therapy may be... 25 (HealthDay News) -- A new study challenges the... impairs the immune system,s ability to restore it...tive antiretroviral therapy (HAART). , From 50 ...re also infected with HCV. Intravenous drug use is...
(Date:7/25/2008)... GA July 24, 2008 Being overweight or obese is n... but is also a public health issue that impacts ot... Health Services Research reveals that the extra ...eople could place a significant financial burden o...f dollars across the entire current Medicare popul...
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Hunger Is Happening National Food Drive a Huge Success -- Donations Will Serve 68,000 Meals 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2
...y increase a person’s risk of developing dementia ...e effect.// In a recent study conducted, researche...n 20 years. They found those who were obese in mid...dementia later in life. Also, patients who had hig...
...s toll on active baby boomers. Arthritis followed ...//for many of the 78 million middle-aged Americans... ahead. Michael Baroli is finally back on his feet... directing. His glamour photography business depen...
...cancer diagnosed among men in the United States --...e several // treatment options, but new research s...ogether. Doctors hope that the drug -- finasteri...ng prostate cancer. In smaller doses, it’s commonl...
... a way to diagnose melancholic depression using an.../ levels of certain substances in the brain. Melan...arked by insomnia, loss of appetite, and loss of p...evels of the inhibitory transmitter GABA and high ...
Other Medicine News:
(Date:7/24/2008)... WASHINGTON, July 24 /PRNewswire-USNewswire/ --...t" do not tell the whole story. The small scale,p...d online in Human,Reproduction, is based on recoll... containing soyfoods. "This study is confounded by...ewed with a great deal of,caution," warned Dr. Tam...
(Date:7/24/2008)... SOPHIA ANTIPOLIS, France, July 24 /PRNewswire-...ay announced the top-line results from the 52-week...llowing the completion of,the 301 phase 3 study fo...safety findings and efficacy was maintained for th...he patients, global assessment scale. In,addition,...
(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ --... of Justice:, Chairman Conyers, Ranking Member Sm...he opportunity to testify today., Since I appeare...ave,become even better acquainted with the talente...tment and with the work they do, and I have come t...
(Date:7/23/2008)... SEATTLE, July 23 /- Den... that it expects the Independent Data,Monitoring C...rim analysis,of overall survival relating to the C...e AdenoCarcinoma Treatment, also known as D9902B) ...ENGE is the Company,s investigational,active cellu...
Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 1New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 2New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 3Nicotine addiction slashed in test of new cigarette smoking strategy 6279 1Nicotine addiction slashed in test of new cigarette smoking strategy 6279 2Nicotine addiction slashed in test of new cigarette smoking strategy 6279 3Anpath Group Inc Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority 28Metro 29 846 1Anpath Group Inc Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority 28Metro 29 846 2Anpath Group Inc Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority 28Metro 29 846 3Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 1209 1Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 1209 2Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 1209 3Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 1209 4
Aegis CheckPoint is an automated, wireless, computerized remote temperature monitoring, recording, logging and alert system for refrigerator, freezer, incubator and water bath to replace chart record
This requiring no water for use, it provides convenient, long-lasting hand hygiene to physically clean hands when routine hand washing is either not an option or is not convenient. Hibistat allows yo
BioSoft alcohol gel hand antiseptic with soothing moisturizers is a fast-acting, broad-spectrum antimicrobial solution. BioSoft alcohol gel hand antiseptic applies easily, requires no rinsing and dri
Exidine® 2% CHG Brushless Surgical Scrub offers exceptional persistence and broad-spectrum antimicrobial activity.
Medicine Products: